Yokohama, Japan

Kazuko Mizutani


Average Co-Inventor Count = 7.8

ph-index = 1


Company Filing History:


Years Active: 1980-1982

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuko Mizutani: Innovator in Pharmaceutical Chemistry

Introduction

Kazuko Mizutani is a notable inventor in the field of pharmaceutical chemistry, recognized for her contributions to the development of antibacterial agents and anti-hypertensive compounds. Based in Yokohama, Japan, she has made significant strides in the production of innovative chemical derivatives.

Latest Patents

Mizutani holds 2 patents, with her latest inventions focusing on advanced processes for synthesizing important pharmaceutical compounds. One of her notable patents is for a process for the production of a 7-methoxycephalosporine derivative. This invention provides an efficient method for creating a new antibacterial agent, utilizing inexpensive starting materials and minimizing side reactions during the synthesis process. Another significant patent involves 5-substituted picolinic acid derivatives, which are represented by a specific chemical formula. These compounds are useful as anti-hypertensive agents and include a detailed process for their preparation.

Career Highlights

Throughout her career, Kazuko Mizutani has worked with prominent companies such as Meiji Seika Kaisha, Ltd. and Meuji Seika Kaisha Ltd. Her work has contributed to advancements in pharmaceutical research and development, particularly in the synthesis of compounds that address critical health issues.

Collaborations

Mizutani has collaborated with esteemed colleagues, including Takashi Tsuruoka and Shigeharu Inouye. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Kazuko Mizutani's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. Her patents and collaborations highlight her commitment to advancing medical science through effective chemical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…